Axon Enterprise, Inc. (NASDAQ:AXON) Holdings Raised by Wolff Wiese Magana LLC

Wolff Wiese Magana LLC increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 625 shares of the biotechnology company’s stock after purchasing an additional 33 shares during the quarter. Wolff Wiese Magana LLC’s holdings in Axon Enterprise were worth $371,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of AXON. Quent Capital LLC raised its position in Axon Enterprise by 1,875.0% during the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the period. Prestige Wealth Management Group LLC boosted its holdings in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the period. Brooklyn Investment Group purchased a new position in Axon Enterprise during the third quarter valued at approximately $41,000. Planning Capital Management Corp lifted its position in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares in the last quarter. Finally, Friedenthal Financial acquired a new position in shares of Axon Enterprise in the third quarter worth $51,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, TD Cowen initiated coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target on the stock. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $504.92.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $590.53 on Wednesday. The firm has a market capitalization of $45.03 billion, a PE ratio of 152.59, a PEG ratio of 14.19 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $246.99 and a 1-year high of $698.67. The business’s 50 day moving average is $610.03 and its 200-day moving average is $452.93.

Insider Activity

In related news, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total value of $860,077.66. Following the sale, the director now owns 2,392 shares of the company’s stock, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This represents a 3.96 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,545 shares of company stock worth $30,721,337. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.